Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.71 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.71 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.71 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.71 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.66 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.66 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.66 |
| ▸ | HDAC10 | Q969S8 | 2/20 | 0.66 |
| ▸ | HDAC11 | Q96DB2 | 2/20 | 0.66 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.66 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.66 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.66 |
| ▸ | EPHX1 | P07099 | 6/20 | 0.60 |
| ▸ | TRPV1 | Q8NER1 | 4/20 | 0.59 |
| ▸ | CNR2 | P34972 | 4/20 | 0.59 |
| ▸ | CNR1 | P21554 | 3/20 | 0.59 |
| ▸ | MEN1 | O00255 | 1/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.58 |
| ▸ | MAPT | P10636 | 1/20 | 0.58 |
| ▸ | HPGD | P15428 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1457453 | 1.00 | SMN1; SMN2 (0.71) | SMN1; SMN2GNAI3GNAO1GNAI1HDAC3 | |
| SCHEMBL21558189 | 1.00 | SMN1; SMN2 (0.71) | SMN1; SMN2GNAI3GNAO1GNAI1HDAC3 | |
| SCHEMBL17335659 | 0.98 | SMN1; SMN2 (0.74) | SMN1; SMN2GNAI3GNAO1GNAI1HDAC3 | |
| Hexadecanoic Acid Cyclopentylamide SCHEMBL1456473 | 0.96 | SMN1; SMN2 (0.78) | SMN1; SMN2GNAI3GNAO1GNAI1HDAC3 | |
| SCHEMBL27755204 | 0.96 | SMN1; SMN2 (0.78) | SMN1; SMN2GNAI3GNAO1GNAI1HDAC3 | |
| SCHEMBL1456736 | 0.96 | SMN1; SMN2 (0.78) | SMN1; SMN2GNAI3GNAO1GNAI1HDAC3 | |
| N-Cyclopentyldecanamide SCHEMBL692378 | 0.96 | SMN1; SMN2 (0.78) | SMN1; SMN2GNAI3GNAO1GNAI1HDAC3 | |
| SCHEMBL28342770 | 0.96 | SMN1; SMN2 (0.78) | SMN1; SMN2GNAI3GNAO1GNAI1HDAC3 | |
| SCHEMBL11525129 | 0.96 | SMN1; SMN2 (0.78) | SMN1; SMN2GNAI3GNAO1GNAI1HDAC3 | |
| SCHEMBL21442874 | 0.95 | SMN1; SMN2 (0.75) | SMN1; SMN2GNAI3GNAO1GNAI1HDAC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1592418-B1 | USE OF ENDOCANNABINOID-LIKE COMPOUNDS FOR TREATING CNS DEGENERATIVE DISORDERS | RES & INNOVATION S P A (IT) | 2017-09-06 | — | — | EP | disclosed |
| EP-1900365-B9 | Endocannabinoid-like compounds and their use for treating dermatitis | RES & INNOVATION S P A (IT) | 2012-01-18 | — | — | EP | disclosed |
| EP-1900365-B1 | Endocannabinoid-like compounds and their use for treating dermatitis | RES & INNOVATION S P A (IT) | 2011-03-30 | — | — | EP | disclosed |
| EP-1900365-A2 | New endocannabinoid-like compounds and their use | RESEARCH & INNOVATION SOC. COOP. A R.L. (IT) | 2008-03-19 | — | — | EP | disclosed |
| EP-1592418-A2 | USE IN THERAPY OF ENDOCANNABINOID-LIKE COMPOUNDS | Research & Innovation Soc. Coop. A R.L. (IT) | 2005-11-09 | — | — | EP | disclosed |
| WO-2004069240-A2 | USE IN THERAPY OF ENDOCANNABINOID-LIKE COMPOUNDS | RESEARCH & INNOVATION SOC. COOP. A. R. L. (IT) | 2004-08-19 | — | — | WO | disclosed |